Kyrgyzstan vs Peru: Previously treated cases tested for RR-/MDR-TB
Kyrgyzstan
95.0%
in 2024
Peru
95.0%
in 2024
Kyrgyzstan rank
66th
Peru rank
66th
Previously treated cases tested for RR-/MDR-TB over time
- Kyrgyzstan
- Peru
How they compare
Kyrgyzstan currently reports 95.0% against 95.0% in Peru, a difference of 0.0%.
The two have swapped places 4 times across 17 shared years of data; in 2005 it was Peru ahead.
Kyrgyzstan ranks 66th and Peru ranks 66th of 180 countries.
Across the 3 decades both report, Kyrgyzstan averaged higher in 1 and Peru in 2.
Head to head by decade
| Decade | Kyrgyzstan | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.4% | 27.2% | 0.8% | Peru |
| 2010s | 70.6% | 77.4% | 6.9% | Peru |
| 2020s | 93.8% | 82.4% | 11.4% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Kyrgyzstan or Peru?
- Kyrgyzstan, at 95.0% against 95.0% in Peru as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Kyrgyzstan and Peru?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Peru?
- 17 years are reported by both, from 2005 to 2024.
- How do Kyrgyzstan and Peru rank globally for previously treated cases tested for rr-/mdr-tb?
- Kyrgyzstan ranks 66th and Peru ranks 66th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.